BlackRock’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,575,092
Closed -$142M 5316
2024
Q1
$142M Buy
3,575,092
+516,594
+17% +$20.5M ﹤0.01% 1841
2023
Q4
$58.3M Buy
3,058,498
+706,581
+30% +$13.5M ﹤0.01% 2339
2023
Q3
$26.9M Buy
2,351,917
+70,225
+3% +$804K ﹤0.01% 2723
2023
Q2
$23.5M Buy
2,281,692
+728,772
+47% +$7.49M ﹤0.01% 2870
2023
Q1
$12M Buy
1,552,920
+116,060
+8% +$896K ﹤0.01% 3153
2022
Q4
$10.6M Buy
1,436,860
+509,137
+55% +$3.74M ﹤0.01% 3310
2022
Q3
$6.68M Buy
927,723
+49,355
+6% +$355K ﹤0.01% 3558
2022
Q2
$7.48M Buy
878,368
+155,230
+21% +$1.32M ﹤0.01% 3569
2022
Q1
$6.49M Sell
723,138
-5,710
-0.8% -$51.2K ﹤0.01% 3732
2021
Q4
$10.1M Buy
728,848
+181,066
+33% +$2.51M ﹤0.01% 3604
2021
Q3
$5.84M Buy
547,782
+3,627
+0.7% +$38.7K ﹤0.01% 3837
2021
Q2
$4.9M Buy
544,155
+517,399
+1,934% +$4.66M ﹤0.01% 3821
2021
Q1
$284K Buy
26,756
+1,001
+4% +$10.6K ﹤0.01% 4620
2020
Q4
$325K Sell
25,755
-4,990
-16% -$63K ﹤0.01% 4328
2020
Q3
$270K Buy
30,745
+841
+3% +$7.39K ﹤0.01% 4253
2020
Q2
$291K Buy
29,904
+6,363
+27% +$61.9K ﹤0.01% 4219
2020
Q1
$68K Sell
23,541
-540
-2% -$1.56K ﹤0.01% 4341
2019
Q4
$92K Sell
24,081
-120
-0.5% -$458 ﹤0.01% 4396
2019
Q3
$96K Sell
24,201
-660
-3% -$2.62K ﹤0.01% 4397
2019
Q2
$105K Sell
24,861
-85
-0.3% -$359 ﹤0.01% 4410
2019
Q1
$171K Sell
24,946
-854
-3% -$5.85K ﹤0.01% 4216
2018
Q4
$94K Sell
25,800
-244
-0.9% -$889 ﹤0.01% 4318
2018
Q3
$165K Buy
26,044
+549
+2% +$3.48K ﹤0.01% 4300
2018
Q2
$192K Buy
25,495
+3,532
+16% +$26.6K ﹤0.01% 4257
2018
Q1
$177K Sell
21,963
-153
-0.7% -$1.23K ﹤0.01% 4186
2017
Q4
$247K Buy
22,116
+755
+4% +$8.43K ﹤0.01% 4118
2017
Q3
$247K Buy
21,361
+1,932
+10% +$22.3K ﹤0.01% 4120
2017
Q2
$187K Sell
19,429
-3,363
-15% -$32.4K ﹤0.01% 4200
2017
Q1
$266K Buy
+22,792
New +$266K ﹤0.01% 4099